This inventor holds 1 USPTO granted patent. Top assignee: Becton Dickinson and Company Limited. Active years: 1986.
Company Filing History:
Years Active: 1986
Title: The Innovative Contributions of Peter Stopa
Introduction
Peter Stopa is a notable inventor based in Timonium, MD (US). He has made significant contributions to the field of medical diagnostics, particularly with his innovative patent related to the detection of Group A Streptococcus.
Latest Patents
Peter Stopa holds a patent for a diagnostic test for Streptococcus A. This invention determines the presence of Group A Streptococcus in a biological specimen by detecting the Streptococcus A antigen. The process involves collecting a biological specimen with an applicator that has a plastic stick and a rayon swab. The swab is then placed in an extraction reagent containing enzymes produced by the bacterium Streptomyces albus. These enzymes release the antigen from the fiber. An aliquot of the extraction medium is mixed with an indicator reagent containing an antibody that reacts with the antigen. The occurrence or non-occurrence of an antibody-antigen reaction indicates the presence or absence of Group A Streptococcus in the biological specimen. This innovative approach enhances the accuracy and efficiency of diagnosing streptococcal infections.
Career Highlights
Peter Stopa is associated with Becton Dickinson and Company Limited, where he applies his expertise in medical technology and diagnostics. His work has contributed to advancements in healthcare and improved patient outcomes.
Collaborations
Some of his notable coworkers include Robert W. Rosenstein and Kim P. Aspden. Their collaboration has likely fostered an environment of innovation and shared knowledge within the company.
Conclusion
Peter Stopa's contributions to medical diagnostics through his patent for a diagnostic test for Streptococcus A exemplify the impact of innovation in healthcare. His work continues to influence the field and improve diagnostic methods for streptococcal infections.